Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension.
Van Buren PN, Inrig JK.
Semin Dial. 2017 Nov;30(6):545-552. doi: 10.1111/sdi.12631. Epub 2017 Jun 30.
Hypertension and Heart Failure: Prevention, Targets, and Treatment.
Di Palo KE, Barone NJ.
Cardiol Clin. 2022 May;40(2):237-244. doi: 10.1016/j.ccl.2021.12.011.
Diuretics in the treatment of hypertension.
Blowey DL.
Pediatr Nephrol. 2016 Dec;31(12):2223-2233. doi: 10.1007/s00467-016-3334-4. Epub 2016 Mar 16.
Calcium channel blockers: differences between subclasses.
Frishman WH.
Am J Cardiovasc Drugs. 2007;7 Suppl 1:17-23. doi: 10.2165/00129784-200707001-00003.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees.
Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5.
Geburtshilfe: hypertensive Erkrankungen in der Schwangerschaft.
Buddeberg BS, Girard T.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2017 Mar;52(3):184-195. doi: 10.1055/s-0042-105990. Epub 2017 Mar 16.
Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial.
Liu L, Xie X, Pan Y, Wang A, Wei Y, Liu J, Nie X, Liu D, Zhao Z, Wang P, Shen S, Zhong C, Xu T, Wang D, Wang GC, Song D, Ma Y, Zhao J, Jiang Y, Jing J, Meng X, Obst K, Chen CS, Wang D, Wang Y, Zhang Y, Wang Y, He J; CATIS-2 Investigators.
BMJ. 2023 Oct 9;383:e076448. doi: 10.1136/bmj-2023-076448.
New Horizons in orthostatic hypotension.
Frith J, Parry SW.
Age Ageing. 2017 Mar 1;46(2):168-174. doi: 10.1093/ageing/afw211.
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.
He J, Ouyang N, Guo X, Sun G, Li Z, Mu J, Wang DW, Qiao L, Xing L, Ren G, Zhao C, Yang R, Yuan Z, Wang C, Shi C, Liu S, Miao W, Li G, Chen CS, Sun Y; CRHCP Study Group.
Lancet. 2023 Mar 18;401(10380):928-938. doi: 10.1016/S0140-6736(22)02603-4. Epub 2023 Mar 2.
Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery.
Marcucci M, Chan MTV, Painter TW, Efremov S, Aguado HJ, Astrakov SV, Kleinlugtenbelt YV, Patel A, Cata JP, Amir M, Kirov M, Leslie K, Duceppe E, Borges FK, de Nadal M, Tandon V, Landoni G, Likhvantsev VV, Lomivorotov V, Sessler DI, Martínez-Zapata MJ, Xavier D, Fleischmann E, Wang CY, Meyhoff CS, Wittmann M, Torres D, Highton D, Jacka M, B V, Zarnke K, Sidhu RS, Oriani G, Ayad S, Minear S, Weaver TE, Ruetzler K, Brusasco C, Parlow JL, Maxwell E, Miller S, Mrkobrada M, Bhatt KSC, Rahate P, Kowark A, De Blasio G, Ofori SN, Conen D, Srinathan S, Szczeklik W, Jayaram R, Ellerkmann RK, Momeni M, Copland I, Vincent J, Balasubramanian K, Li Z, Wang MK, Li D, McGillion MH, Kurz A, Sharma M, Short TG, Devereaux PJ; cogPOISE-3 Trial Investigators and Study Groups.
Ann Intern Med. 2025 Jul;178(7):909-920. doi: 10.7326/ANNALS-24-02841. Epub 2025 Jun 3.
